HUP0202738A2 - Ló herpeszvírus hőérzékeny mutánsa és az abból készített élő oltóanyag - Google Patents

Ló herpeszvírus hőérzékeny mutánsa és az abból készített élő oltóanyag

Info

Publication number
HUP0202738A2
HUP0202738A2 HU0202738A HUP0202738A HUP0202738A2 HU P0202738 A2 HUP0202738 A2 HU P0202738A2 HU 0202738 A HU0202738 A HU 0202738A HU P0202738 A HUP0202738 A HU P0202738A HU P0202738 A2 HUP0202738 A2 HU P0202738A2
Authority
HU
Hungary
Prior art keywords
temperature sensitive
herpes virus
live vaccine
mutant
sensitive mutant
Prior art date
Application number
HU0202738A
Other languages
English (en)
Inventor
Jay R. Patel
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of HUP0202738A2 publication Critical patent/HUP0202738A2/hu
Publication of HUP0202738A3 publication Critical patent/HUP0202738A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/27—Equine rhinopneumonitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16763—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A találmány tárgya ló vetélési vírus (EHV-1) mutánsa, amely hőérzékenya gazdaállat testhőmérsékletén, közelebbről 38,5 °C-on vagymagasabban. A hőérzékeny mutáns alkalmazható vakcinálásban fogékonyállatok EHV-1-fertőzés elleni védelmére. A találmány tárgyát képeziktovábbá a mutánsból származó élő oltóanyagok. Ó
HU0202738A 1999-09-10 2000-09-11 Equine herpes virus temperature sensitive mutant and live vaccine thereof HUP0202738A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99202933 1999-09-10
PCT/EP2000/008944 WO2001017553A1 (en) 1999-09-10 2000-09-11 Equine herpes virus temperature sensitive mutant and live vaccine thereof

Publications (2)

Publication Number Publication Date
HUP0202738A2 true HUP0202738A2 (hu) 2002-12-28
HUP0202738A3 HUP0202738A3 (en) 2003-12-29

Family

ID=8240619

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202738A HUP0202738A3 (en) 1999-09-10 2000-09-11 Equine herpes virus temperature sensitive mutant and live vaccine thereof

Country Status (8)

Country Link
EP (1) EP1216054A1 (hu)
JP (1) JP2004532601A (hu)
AU (1) AU778157B2 (hu)
CA (1) CA2383980A1 (hu)
HU (1) HUP0202738A3 (hu)
MX (1) MXPA02002566A (hu)
RU (1) RU2252253C2 (hu)
WO (1) WO2001017553A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129722A1 (en) 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh gM-negative EHV-mutants
AR040601A1 (es) 2002-07-19 2005-04-13 Boehringer Ingelheim Vetmed Mutantes ehv negativos de gm sin elementos heterologos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110433A (en) * 1976-04-23 1978-08-29 Philips Roxane, Inc. Equine rhinopneumonitis virus
US5972666A (en) * 1996-07-26 1999-10-26 G. D. Searle & Co. Assembly-deficient herpesvirus vaccine
US5853715A (en) * 1996-08-16 1998-12-29 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same

Also Published As

Publication number Publication date
AU1271101A (en) 2001-04-10
EP1216054A1 (en) 2002-06-26
AU778157B2 (en) 2004-11-18
HUP0202738A3 (en) 2003-12-29
MXPA02002566A (es) 2002-10-23
JP2004532601A (ja) 2004-10-28
RU2002109231A (ru) 2004-02-27
RU2252253C2 (ru) 2005-05-20
WO2001017553A1 (en) 2001-03-15
CA2383980A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
EP1854886A3 (en) Cold-adapted equine influenza viruses
BR9812232A (pt) Vìrus sincicial respiratório (rsv) humano subgrupo b, isolado, recombinantemente gerado , atenuado, vacina, processo para imunizar um indivìduo para induzir proteção contra o rsv subgrupo b, composição, processo para produzir rsv subgrupo b infeccioso atenuado, e, molécula isolada de ácido nucleico
HUP0500238A2 (hu) Interleukin-12 alkalmazása állatgyógyászati vakcina adjuvánsként
RU93058614A (ru) Мутант вируса герпеса, композиции, диагностические наборы, способы определения инфекции
WO2001060849A3 (en) Cold-adapted equine influenza viruses
HUP0302664A2 (hu) Vakcináció gazdasejttel asszociált herpeszvírusok ellen
HUP9904171A2 (hu) A ragadós száj- és körömfájás vírusok immunogén peptidjei
MXPA03009763A (es) Vacuna contra el virus de la enfermedad de la fiebre aftosa.
HUP0202738A2 (hu) Ló herpeszvírus hőérzékeny mutánsa és az abból készített élő oltóanyag
MXPA02005506A (es) Clonacion de un gen que codifica una racemasa de aminoacido derivada de tripanosoma cruzi, y usos del mismo.
ATE366819T1 (de) Genetische immunisierung gegen zervixkarzinom
WO2001074386A3 (en) Cold-adapted equine influenza viruses
ES2132330T3 (es) Vacuna para la proteccion de caballos frente a la infeccion por el virus del herpes equino.
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
WO2004100640A3 (en) Marek’s disease virus vaccine
BR0304750A (pt) Mutante de herpesvìrus bovino tipo 5, vacina dirigida contra a encefalite viral bovina (bhv-s) e o vìrus rábico e método de preparação da vacina
HUP0002374A2 (hu) Egy diszfunkcionális 71 gén régiót tartalmazó rekombináns 1-es típusú ló herpeszvírus (EHV-1) és alkalmazása vakcinaként
ATE540693T1 (de) Impfung und impfstoffe gegen hundeherpesvirus
ES2105984A1 (es) Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
Schrijver et al. Protective immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV
Thomson et al. Foot and Mouth Disease in Southern Africa: Re-evaluation of the approach to control
UA30385A (uk) Штам вірусу інфекційного ринотрахеїту ipt-lg /іеквм/ для виготовлення вакцини
Lane Canine vaccination policy.
Terzić et al. Proportion of CD4a+ CD8a+ and wCD21+ cells in peripheral blood of pigs vaccinated against classical swine fever
WO2005009372A3 (en) Marek’s disease virus vaccine

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees